Search clinical trials for: Lenalidomide (Revlimid®)
Total 14694 results
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsTerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LeukemiaUnited States
-
University Hopsital Schleswig Holstein Campus LübeckRecruitingNewly Diagnosed Multiple MyelomaGermany
-
Bristol-Myers SquibbAbbVieCompleted
-
University of California, DavisCelgeneActive, not recruiting
-
NYU Langone HealthMerck Sharp & Dohme LLCTerminatedRelapsed Non-Hodgkin Lymphoma | Relapsed Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)WithdrawnChronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Italy, Poland, United States, Thailand, United Kingdom, Belgium, Turkey, Czechia
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; Sanofi; AmgenActive, not recruiting
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
Bristol-Myers SquibbAbbottTerminatedNewly Diagnosed, Previously Untreated Multiple MyelomaUnited States, Poland, Italy, Greece
-
Weill Medical College of Cornell UniversityCelgeneTerminatedMyelodysplastic SyndromeUnited States
-
Ohio State University Comprehensive Cancer CenterNovartis; CelgeneCompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
Peking Union Medical College HospitalCelgene CorporationCompleted
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited States
-
Masonic Cancer Center, University of MinnesotaCelgene CorporationTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Institut CurieNational Cancer Institute, FranceRecruitingLymphoma, Large B-Cell, Diffuse | Central Nervous System Neoplasms, PrimaryFrance
-
Emory UniversityNovartis; CelgeneCompletedNeuroendocrine Tumors | Solid Organ Malignancies | Adenoidcystic CarcinomaUnited States
-
CelgeneCompletedAnemiaUnited States, Belgium, Spain, United Kingdom, Austria, Canada, Germany, Portugal, France, Australia, Israel, Japan, Italy, Czechia, Poland, Turkey
-
Florian Strasser, MD ABHPMCelgeneCompletedCancer Cachexia SyndromeSwitzerland
-
Heinrich-Heine University, DuesseldorfTerminatedMyelodysplastic Syndrome MDSGermany
-
Swiss Group for Clinical Cancer ResearchCompleted
-
City of Hope Medical CenterTerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Germany, Puerto Rico
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom... and other conditionsUnited States
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
David Rizzieri, MDGenzyme, a Sanofi Company; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
European Myeloma NetworkCompletedMultiple Myeloma | Hematologic MalignanciesSpain, Sweden, Germany, Italy
-
University College, LondonCompletedChronic Lymphocytic LeukemiaUnited Kingdom
-
IRCCS Centro di Riferimento Oncologico della BasilicataCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterRecruitingHodgkin Lymphoma | B-Cell Lymphoma | Relapsed B-cell NHLUnited States
-
James RubensteinGenentech, Inc.; CelgeneCompletedIntraocular Lymphoma | Recurrent/Refractory CNSUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemiaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Seoul National University Bundang HospitalSamyang BioPharmRecruitingCentral Nervous System LymphomaKorea, Republic of
-
Duke UniversityMillennium Pharmaceuticals, Inc.; Duke Cancer InstituteTerminated
-
Fox Chase Cancer CenterMerck Sharp & Dohme LLC; CelgeneTerminatedNonsmall Cell Lung Cancer | Relapsed or Refractory Solid TumorsUnited States
-
Mayo ClinicCelgene CorporationCompletedIgG4-related Disease | Retroperitoneal Fibrosis | Autoimmune Pancreatitis | IgG4-related Sclerosing Cholangitis | Immunoglobulin G Subclass 4 Related DiseaseUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedGraft-versus-Host DiseaseUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationActive, not recruitingLymphoma | LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMultiple MyelomaUnited States
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
Hackensack Meridian HealthActive, not recruitingMantle Cell LymphomaUnited States
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Roswell Park Cancer InstituteCelgene CorporationCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada
-
Celgene CorporationPrologue Research InternationalCompletedMultiple MyelomaUnited States, Canada